Finance

Lists
TAK:NYSE
Takeda Pharmaceutical Co Ltd
US$ १८.५२
-०.८६%
(-०.१६) 1D
US$ १८.५५
+०.१६% (+०.०३०)
Pre-market
Closed: अक्टोबर १३, १६:००:०६ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TAK...
Open
US$ १८.७३
High
US$ १८.८२
Low
US$ १८.५२
Mkt. cap
५८.७९ अरब
Avg. vol.
२३.८१ लाख
Volume
२.३० हजार
Dividend
३.४०%
Quarterly dividend
US$ ०.१६
Ex-dividend date
२०२६ सेप्टेम्बर २९
52-wk high
US$ १९.१०
52-wk low
US$ १२.९९
EPS
-US$ ०.३३
Beta
-०.०६
Shares outstanding
३.२० अरब
No. of employees
४७ हजार
Open
US$ १८.७३
High
US$ १८.८२
Low
US$ १८.५२
Mkt. cap
५८.७९ अरब
Avg. vol.
२३.८१ लाख
Volume
२.३० हजार
Dividend
३.४०%
Quarterly dividend
US$ ०.१६
Ex-dividend date
२०२६ सेप्टेम्बर २९
52-wk high
US$ १९.१०
52-wk low
US$ १२.९९
EPS
-US$ ०.३३
Beta
-०.०६
Shares outstanding
३.२० अरब
No. of employees
४७ हजार
News stories
From web sources and news partners
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees४७ हजार
Founded१७८१ जुन १२
Headquarters-
Sector-
Websitetakeda.com
Analyst ratings
Based on 1 analyst giving stock ratings to TAK in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TAK in the last 3 months
Highest
Current US$ १८.५२
US$ ४२.९४ (+१३१.८३%)
Average
US$ ४२.९४ (+१३१.८६%)
Lowest
US$ ४२.९४ (+१३१.८३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Koichi Mamegano
Bank of America Securities
Buy
Maintained
JP¥ ६,८००.००
+३६,६१७.१%
09/14/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
US$ २१.००
+१३.४%
06/04/2026
Last report
२०२६ जुलाई ३०
Fiscal period
Q1 2026
JP¥ ७७.०० / -
०.००%miss
Revenue / Est. (JPY)
१२.२० खरब / ११.५० खरब
+६.१२%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
११.१३ खरब
११.९२ खरब
१०.९५ खरब
१२.२० खरब
Cost of goods sold
३.८० खरब
४.०१ खरब
४.५३ खरब
४.०७ खरब
Cost of revenue
३.८० खरब
४.०१ खरब
४.५३ खरब
४.०७ खरब
Research and development expenses
१.६१ खरब
१.७५ खरब
१.८८ खरब
१.६७ खरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.५४ खरब
२.८३ खरब
२.९२ खरब
२.८७ खरब
Operating expense
५.६३ खरब
६.६१ खरब
५.२० खरब
६.१३ खरब
Total operating expenses
९.४३ खरब
१०.६२ खरब
९.७३ खरब
१०.१९ खरब
Operating income
१.७० खरब
१.२९ खरब
१.२२ खरब
२.०१ खरब
Other non operating income
७७.९६ अरब
-१.९७ खरब
१.८२ खरब
-२८.१४ अरब
EBT including unusual items
२८.१७ अरब
१.३४ खरब
-४.५५ खरब
१.६३ खरब
EBT excluding unusual items
१.२९ खरब
१.१४ खरब
७१.४९ अरब
१.६२ खरब
Income tax expense
३९.९० अरब
३०.१३ अरब
-८६.६२ अरब
४९.४६ अरब
Effective tax rate
१४१.६४%
२२.५१%
१९.०४%
३०.४०%
Other operating expenses
१६.१२ अरब
६७.१३ अरब
-६४.२७ अरब
५३.१७ अरब
Net income
-११.८० अरब
१.०४ खरब
-३.६८ खरब
१.१३ खरब
Net profit margin
-१.०६%
८.७०%
-३३.६६%
९.२८%
Earnings per share
-
-
-
-
Interest and investment income
४३.९२ अरब
१.८१ खरब
-
२४.६१ अरब
Interest expense
-१.६१ खरब
-
-२.४० खरब
-३५.७० अरब
Net interest expenses
-१.१७ खरब
१.८१ खरब
-२.४० खरब
-११.०९ अरब
Depreciation and amortization charges
-
-
-
-
EBITDA
३.५५ खरब
३.२० खरब
१.९३ खरब
३.६४ खरब
Gain or loss from assets sale
३०.३० करोड
३५.८० करोड
१.४६ अरब
-६.०० अरब
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू